SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Why Eli Lilly and Company May Never Get Bought By Valeant Pharmaceuticals International -- Or Anyone Else
June 25, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Beach
The Flip Side: What Valeant Pharmaceuticals International Gets Right About R&D
June 17, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Valeant Pharmaceuticals International’s Debate About Research Are Misleading, Wrong
June 13, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Why Valeant Pharmaceuticals International’s Allergan Inc. R&D Bid Does Not Make Sense
May 28, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Billionaire Outs Valeant Pharmaceuticals International CEO As A Billionaire
April 23, 2014
 · 
1 min read
Bookmark and Share
Business
Valeant Pharmaceuticals International CEO’s Pay Package Draws Praise as a Model
August 24, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Valeant Pharmaceuticals International Chemo Drug Cream May Fade Wrinkles, University of Michigan Study
June 16, 2009
 · 
1 min read
Deals
Valeant Pharmaceuticals International Sells Pan-Asia Marketing Rights to Invida
March 3, 2008
 · 
1 min read
Biotech Beach
The Day In Review: SciClone Pharmaceuticals, Inc. Soars On Positive Melanoma Results
December 22, 2006
 · 
1 min read
Load More
IN THE PRESS
Valeant Completes Tender Offer For Salix
April 1, 2015
 · 
3 min read
BioCapital
Valeant Closes Offering Of $1.45 Billion Of Common Shares
March 27, 2015
 · 
4 min read
Valeant Announces Offering Of $1.45 Billion Of Common Shares
March 17, 2015
 · 
4 min read
Valeant Prices Offering Of $1.45 Billion Of Common Shares
March 17, 2015
 · 
4 min read
Deals
Valeant Announces HSR Clearance For Salix Acquisition
March 16, 2015
 · 
3 min read
Valeant Announces Pricing Of Private Offering Of Senior Notes
March 13, 2015
 · 
6 min read
Pharm Country
Valeant Release: Three New CeraVe Baby Products Awarded National Eczema Association (NEA) Seal Of Acceptance
March 12, 2015
 · 
3 min read
Bio NC
Valeant Comments On Endo International Offer To Acquire Salix
March 12, 2015
 · 
4 min read
Valeant Announces Launch Of Private Offering Of Senior Notes
March 10, 2015
 · 
3 min read
Drug Development
Valeant Release: PROVENGE (sipuleucel-T) Demonstrates Sustained Immune Response Two Years After Treatment In Biochemically-Recurrent Prostate Cancer
February 25, 2015
 · 
6 min read
Load More